19.95
-0.52(-2.54%)
Currency In USD
| Previous Close | 20.47 |
| Open | 20.36 |
| Day High | 20.64 |
| Day Low | 19.93 |
| 52-Week High | 35.72 |
| 52-Week Low | 16.1 |
| Volume | 3.06M |
| Average Volume | 2.52M |
| Market Cap | 2.52B |
| PE | 55.42 |
| EPS | 0.36 |
| Moving Average 50 Days | 25.23 |
| Moving Average 200 Days | 22.93 |
| Change | -0.52 |
If you invested $1000 in Apellis Pharmaceuticals, Inc. (APLS) since IPO date, it would be worth $1,421.95 as of November 06, 2025 at a share price of $19.95. Whereas If you bought $1000 worth of Apellis Pharmaceuticals, Inc. (APLS) shares 5 years ago, it would be worth $554.01 as of November 06, 2025 at a share price of $19.95.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025 at 2:40 p.m. ET. The live conferen
New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week
GlobeNewswire Inc.
Oct 20, 2025 11:00 AM GMT
Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria remission (UPCR ≤0.5 g/g) achieved in one-third of patients and sustained through one yearTwo indirect t
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Oct 16, 2025 11:00 AM GMT
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and we